Daehan New Pharm Co. Ltd (054670) — Cash Flow Quality Index
Daehan New Pharm Co. Ltd (054670) has a Cash Flow Quality Index of 1.70x as of September 2025. Operating cash flow of ₩4.43 Billion exceeds net income of ₩2.61 Billion, indicating high earnings quality where cash backs reported profits. Explore 054670 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Daehan New Pharm Co. Ltd Cash Flow Quality Index (2009–2024)
Historical Cash Flow Quality Index for Daehan New Pharm Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 054670 operating cash flow.
Annual Cash Flow Quality Index for Daehan New Pharm Co. Ltd (2009–2024)
Year-by-year earnings quality comparison for Daehan New Pharm Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.22x | ₩18.95 Billion | ₩15.47 Billion | ▲ +22.2% |
| 2023 | 1.00x | ₩12.57 Billion | ₩12.54 Billion | ▲ +70.9% |
| 2022 | 0.59x | ₩14.25 Billion | ₩24.32 Billion | ▼ -44.5% |
| 2021 | 1.06x | ₩16.58 Billion | ₩15.69 Billion | ▼ -29.7% |
| 2019 | 1.50x | ₩22.89 Billion | ₩15.24 Billion | ▼ -82.0% |
| 2018 | 8.34x | ₩20.47 Billion | ₩2.45 Billion | ▲ +343.3% |
| 2015 | 1.88x | ₩7.80 Billion | ₩4.15 Billion | ▼ -50.0% |
| 2014 | 3.76x | ₩10.02 Billion | ₩2.66 Billion | ▼ -29.1% |
| 2011 | 5.31x | ₩3.42 Billion | ₩643.55 Million | ▲ +183.2% |
| 2009 | -6.38x | ₩-2.30 Billion | ₩360.71 Million | — |